Schizophrenia Clinical Research Trials
Schizophrenia is a severe and chronic mental illness which impacts approximately 1% of the population. A person with schizophrenia experiences changes in the way he or she thinks, feels and behaves.
People with schizophrenia may have a variety of symptoms, ranging from believing in ideas which are obviously not true, or feeling paranoid and suspicious; as if everyone is out to get them. They may become isolated and avoid contact with others. They may hear voices or see visions that they believe are real. Sometimes, they will talk back to the voices or the visions as if they were real.
They may become less able to complete their daily activities such as showering, washing clothes, and eating properly. They may also lack energy and motivation to take part in activities they used to enjoy.
People with schizophrenia may have problems making good decisions, and they may have problems with their memory.
Schizophrenia treatment research is designed to find new ways to prevent, detect, or treat the disease. At CBHHealth, we focus on researching new schizophrenia treatments that can help reduce the symptoms and the suffering associated with this illness.
If you, or someone you know, lives with schizophrenia, please contact us and let’s explore how our upcoming clinical trials might be of assistance in the management and treatment of schizophrenia symptoms.
Our Current Study Sponsors Include:
Our Current Study Medications Include:
- Karuna Compound
- Takeda 831
- Roche Compound